Scleroderma CD4+ T Cells
About: Human CD4+ T Cells are isolated from peripheral blood of IRB-consented donors diagnosed with scleroderma. Suitable for research examining immune dysregulation, fibrosis-associated inflammation, and autoimmune connective tissue disease mechanisms.
Scleroderma CD4+ T Cells
CD4+ T Cells for Fibrosis and Autoimmune Connective Tissue Research
Human CD4+ T Cells are isolated from peripheral blood of IRB-consented donors diagnosed with scleroderma. These helper T lymphocytes contribute to immune dysregulation and fibrosis-associated inflammation characteristic of systemic connective tissue disease. Scleroderma CD4+ T cells are suitable for studies examining immune signaling pathways, cytokine production, and therapeutic strategies targeting autoimmune-driven fibrosis.
Product Features
- Research Use Only (RUO), CD4 positive T cells
- Isolated from clinically confirmed scleroderma donors
- High purity and viability (≥90% CD4+ cells)
- Cryopreserved in CryoStor® CS10 media
- Processed within 24 hours of collection
- IRB-approved protocols with electronic informed consent
Donor Metadata
- Verified diagnosis and clinical history
- Demographic data: age, sex assigned at birth, race/ethnicity
- Treatment background when available
Applications
- Immune dysregulation studies
- Fibrosis-associated inflammation research
- Cytokine signaling analysis
- Autoimmune therapeutic development
- Functional and transcriptomic assays
Compliance and Quality Assurance
- IRB-approved collections and standardized procedures
- 21 CFR Part 11–compliant e-consent system
- HIPAA-compliant data management
Ordering & Customization
Human CD4+ T Cells are available in customizable aliquot sizes. For international orders or documentation needs, please contact learnmore@sanguinebio.com to confirm requirements and availability.
Frequently Asked Questions
1 Answer
All our samples have self-reported infectious disease testing and verified clinical diagnosis. Many of our samples have the option of electronic medical records provided and our prospective collection offers the opportunity for patient reported outcomes and surveys. Learn more here. https://sanguinebio.com/patient-reported-outcomes-pro-surveys-questionnaires/
1 Answer
YES – Certificate of analysis is available upon request.
1 Answer
Lead times vary from ready to ship inventory to prospective studies.
1 Answer
International shipping is available. We also work with a number of distributors. Contact us to discuss options at learnmore@sanguinebio.com.
1 Answer
We have several ordering methods. You can order directly online with a PO or credit card or contact us to have a sales specialist help with your order. https://sanguinebio.com/request-quote/
1 Answer
You can request a quote on this page or contact us at learnmore@sanguinebio.com. https://sanguinebio.com/request-quote/
1 Answer
NO – no minimum order requirements.
1 Answer
For bulk pricing inquiries, please contact: LearnMore@sanguinebio.com
Ask a Question
Need a custom CD4+ T Cells cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.